Navigation Links
Misonix Announces the Sale of Its Labcaire Business for up to $5.6 Million
Date:8/4/2009

FARMINGDALE, N.Y., Aug. 5 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today announced the sale of its Labcaire subsidiary to PuriCore International Limited ("PuriCore") for a total purchase price of up to $5.6 million. Misonix received $3,600,000 at closing and a promissory note in the principal amount of $1,000,000, payable in equal installments of $250,000 on the next four anniversaries of the closing. Misonix will also receive a commission paid on sales for the period commencing on the date of closing and ending on December 31, 2013 of 8% of the pass through Automated Endoscope Reprocessing ("AER") and Drying Cabinet products, and 5% of license fees from any chemical licenses marketed by Labcaire directly associated with sales of AER's, specifically for the disinfection of the endoscope. The aggregate commission payable to Misonix is subject to a maximum payment of $1,000,000.

The financial position of Labcaire as of the fiscal year ended June 30, 2009, which is currently unaudited, includes revenues of $14 million and a net loss of $7,000 as compared to revenues of $13.6 million and a net loss of $389,000 for the fiscal year ended June 30, 2008 which was audited as part of the overall Misonix reported results for that period.

Michael A. McManus, Jr., President and Chief Executive Officer stated, "We are very pleased to have completed the transaction with PuriCore. Our strategy has been to create a medical device company that has proprietary, innovative, high margin products that utilize ultrasound as the core technology and we believe the completion of this transaction further supports that goal. Additionally, the
'/>"/>

SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. Misonix Receives First Award for Forensic Equipment in China
2. Misonix Announces Participation in 2nd International Workshop on Focal Therapy
3. Misonix Subsidiary, Sonora Medical Systems, Achieves ISO 17025 Accreditation
4. Misonix Announces the Purchase of Patents From ProRhythm, Inc.
5. Misonix Announces Attendance at 22nd Annual Symposium on Advanced Wound Care
6. Misonix Announces Participation in Annual Diabetic Foot Global Conference
7. Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009
8. Misonix Announces New HIFU Distribution Agreement For Portugal
9. Misonix Announces New HIFU Distribution Agreement for Romania and Bulgaria
10. Misonix Announces New Distribution Agreement for Portugal
11. Misonix Announces the Sale of Its Ultrasonic Laboratory Business for $3.5 Million to iSonix LLC
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 2HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 3TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2Water conserving irrigation strategies minimize overwatering runoff 60696 1Water conserving irrigation strategies minimize overwatering runoff 60696 2Water conserving irrigation strategies minimize overwatering runoff 60696 3When should flu trigger a school shutdown 3F 60692 1When should flu trigger a school shutdown 3F 60692 2When should flu trigger a school shutdown 3F 60692 3Cholesterol and Cancer 3A Answers and Some New Questions 60688 1Cholesterol and Cancer 3A Answers and Some New Questions 60688 2Cholesterol and Cancer 3A Answers and Some New Questions 60688 3Cholesterol and Cancer 3A Answers and Some New Questions 60688 4Cholesterol and Cancer 3A Answers and Some New Questions 60688 5